MedPath

Response to Lusutrombopag in portal hypertension with Splenomegaly:retrospective study

Not Applicable
Conditions
thrombocytopenia with splenomegaly
Registration Number
JPRN-UMIN000031354
Lead Sponsor
Kitasato University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

1.Patients with a hematologic malignancy. 2.Active malignancy at time of study entry except HCC. 3.Patients who underwent liver transplantation 4.Patients with a severe liver dysfunction (Child-pugh C) 5.Patients with a medical history of thrombosis. 6.Patients with a medical history of thrombotic disease adult patients. 7.Women who are pregnant or breastfeeding 8.Severe GI bleeding. 9.Not appropriate for this study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath